denosumab
amgen,daiichi sankyo
['breast', 'denosumab']
adjuvant bone-protection for hr+ve #breastcancer has come a long way in 20yrs, or has it? clodronate for 2yrs linked to 23% os increase (powles 2006) and now denosumab (gnant #asco22 507) for 3yrs linked to 26% os increase. ? better #adherence to sc cf. po meds
Cancer specialist searching the world for better therapy